Article
Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.
Molecular pain - 28 May 2009
Romero-Sandoval Edgar Alfonso, Horvath Ryan, Landry Russell P, DeLeo Joyce A
Abstract excerpt
BACKGROUND: Cannabinoid receptor type 2 (CBR2) inhibits microglial reactivity through a molecular mechanism yet to be elucidated. We hypothesized that CBR2 activation induces an anti-inflammatory phenotype in microglia by inhibiting extracellular signal-regulated kinase (ERK) pathway, via mitogen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
